Multiple confirmatory trials. How can additional studies be of value?
- 1 October 1991
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 2 (9) , 625-627
- https://doi.org/10.1093/oxfordjournals.annonc.a058037
Abstract
J. Michael Hamilton, M.D.; Editorial: Multiple confirmatory trials. How can additional studies be of value?, Annals of Oncology, Volume 2, Issue 9, 1 October 1Keywords
This publication has 6 references indexed in Scilit:
- Folinic acid + 5-Fluorouracil (5-FU) versus equidose 5-FU in advanced colorectal cancer. Phase III study of ‘GISCAD’ (Italian Group for the Study of Digestive Tract Cancer)Annals of Oncology, 1991
- Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.Journal of Clinical Oncology, 1989
- A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.Journal of Clinical Oncology, 1989
- Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancerCancer, 1989
- The role of overviews in cancer therapeuticsStatistics in Medicine, 1987
- Fluorinated Pyrimidines, A New Class of Tumour-Inhibitory CompoundsNature, 1957